Citius Pharmaceuticals, Inc. (CTXR:NASDAQ) closed at $0.497 on November 19, 2026, down 2.64% on the day. The stock trades 67.7% below its 52-week high of $1.54 and 34.4% above its 52-week low of $0.370. Over the past year, it lost 49.8%. Citius Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 19, 2025, CTXR closed higher on 107 days (42%). Its best day was March 31, 2026 (+32.35%) and its worst was August 17, 2026 (-25.66%). The stock moved 10% or more in a single session 29 times. It opened at least 5% above the previous day's high 2 times.
Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
Find more stocks like CTXR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.